The Value of Atorvastatin Over the Product Life Cycle in the United States
The Value of Atorvastatin Over the Product Life Cycle in the United States
About this item
Full title
Author / Creator
Publisher
Bridgewater, NJ: EM Inc USA
Journal title
Language
English
Formats
Publication information
Publisher
Bridgewater, NJ: EM Inc USA
Subjects
More information
Scope and Contents
Contents
Abstract Background US health care reform mandates the reduction of wasteful health care spending while maintaining quality of care. Introducing new drugs into crowded therapeutic classes may be viewed as offering “me-too” (new drugs with a similar mechanism of action compared to existing drugs) drugs without incremental benefit. This article prese...
Alternative Titles
Full title
The Value of Atorvastatin Over the Product Life Cycle in the United States
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_901306798
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_901306798
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2011.08.014
